Shareholders' Deficit (Tables)
|
12 Months Ended |
Dec. 31, 2021 |
|---|
| Stockholders' Equity Note [Abstract] |
|
| Schedule of redemption period |
|
Redemption Period
|
|
Redemption
Percentage |
| 1. The period beginning on the date of the issuance of shares of Series A Preferred Stock and ending on the date which is sixty days following the Issuance Date. |
|
100% |
| 2. The period beginning on the date that is sixty-one days from the Issuance Date and ending ninety days following the Issuance Date. |
|
107% |
| 3. The period beginning on the date that is ninety-one days from the Issuance Date and ending one hundred twenty days following the Issuance Date. |
|
112% |
| 4. The period beginning on the date that is one hundred twenty-one days from the Issuance Date and ending one hundred fifty days following the Issuance Date. |
|
117% |
| 5. The period beginning on the date that is one hundred fifty-one days from the Issuance Date and ending one hundred eighty days following the Issuance Date. |
|
120% |
|
| Schedule of activity related to non-vested shares |
| |
|
Number of
Non-Vested
Shares |
|
|
Weighted
Average
Grant Date
Fair Value |
|
| Non-vested, December 31, 2019 |
|
|
17,675,299 |
|
|
$ |
0.23 |
|
| Granted |
|
|
7,450,000 |
|
|
|
0.04 |
|
| Shares vested |
|
|
(1,298,373 |
) |
|
|
(0.41 |
) |
| Non-vested, December 31, 2020 |
|
|
23,826,926 |
|
|
|
0.16 |
|
| Granted |
|
|
6,194,767 |
|
|
|
0.06 |
|
| Forfeited |
|
|
(700,000 |
) |
|
|
(0.07 |
) |
| Shares vested |
|
|
(15,051,573 |
) |
|
|
(0.14 |
) |
| Non-vested, December 31, 2021 |
|
|
14,270,120 |
|
|
$ |
0.14 |
|
|
| Schedule of stock option activities |
| |
|
Number of
Options |
|
|
Weighted
Average
Exercise
Price |
|
|
Weighted
Average
Remaining
Contractual
Term (Years) |
|
|
Aggregate
Intrinsic
Value |
|
| Balance Outstanding, December 31, 2019 |
|
|
8,445,698 |
|
|
$ |
0.40 |
|
|
|
|
|
|
|
|
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
| Balance Outstanding, December 31, 2020 |
|
|
8,445,698 |
|
|
|
0.40 |
|
|
|
5.10 |
|
|
$ |
48,000 |
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Balance Outstanding, December 31, 2021 |
|
|
8,445,698 |
|
|
$ |
0.40 |
|
|
|
4.10 |
|
|
$ |
0 |
|
| Exercisable, December 31, 2021 |
|
|
8,445,698 |
|
|
$ |
0.40 |
|
|
|
4.10 |
|
|
$ |
0 |
|
|
| Schedule of warrant activities |
| |
|
Number of
Warrants |
|
|
Weighted
Average
Exercise
Price |
|
|
Weighted
Average
Remaining
Contractual
Term (Years) |
|
|
Aggregate
Intrinsic
Value |
|
| Balance Outstanding December 31, 2019 |
|
|
2,050,000 |
|
|
$ |
0.10 |
|
|
|
|
|
|
|
|
|
| Exercised |
|
|
288,750 |
|
|
|
0.10 |
|
|
|
|
|
|
|
|
|
| Cancelled |
|
|
(288,750 |
) |
|
|
(0.10 |
) |
|
|
|
|
|
|
|
|
| Balance Outstanding December 31, 2020 |
|
|
2,050,000 |
|
|
|
0.05 |
|
|
|
3.66 |
|
|
$ |
137,000 |
|
| Granted |
|
|
16,500,000 |
|
|
|
0.05 |
|
|
|
- |
|
|
|
- |
|
| Exercised |
|
|
(1,050,000 |
) |
|
|
(0.01 |
) |
|
|
- |
|
|
|
- |
|
| Balance Outstanding December 31, 2021 |
|
|
17,500,000 |
|
|
$ |
0.05 |
|
|
|
4.67 |
|
|
$ |
- |
|
| Exercisable, December 31, 2021 |
|
|
17,500,000 |
|
|
$ |
0.05 |
|
|
|
4.67 |
|
|
$ |
- |
|
|